Article
Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer.
Journal of surgical oncology - 1 Jan 2008
Sasa Mitsunori, Bando Yoshimi, Takahashi Masako, Hirose Toshiyuki, Nagao Taeko
Abstract excerpt
BACKGROUND: Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative and Her2-negative) can be classified into two subtypes: basal and non-basal phenotype. Among these subtypes the basal phenotype is associated with poor outcome. Ordinarily, clinicopathological te...
Topics
- Adult
- Aged
- Breast Neoplasms
- Female
- Humans
- Immunohistochemistry
- Keratin-14
- Keratin-17
- Keratin-5
- Keratin-6
- Lymphatic Metastasis
- Middle Aged
- Phenotype
- Receptor, ErbB-2
- Receptors, Estrogen
- Receptors, Progesterone